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MicroRNA-145 Protects Cardiomyocytes against
Hydrogen Peroxide (H2O2)-Induced Apoptosis through
Targeting the Mitochondria Apoptotic Pathway
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Abstract
MicroRNAs, a class of small and non-encoding RNAs that transcriptionally or post-transcriptionally modulate the expression
of their target genes, has been implicated as critical regulatory molecules in many cardiovascular diseases, including
ischemia/reperfusion induced cardiac injury. Here, we report microRNA-145, a tumor suppressor miRNA, can protect
cardiomyocytes from hydrogen peroxide (H2O2)-induced apoptosis through targeting the mitochondrial pathway.
Quantitative real-time PCR (qPCR) demonstrated that the expression of miR-145 in either ischemia/reperfused mice
myocardial tissues or H2O2-treated neonatal rat ventricle myocytes (NRVMs) was markedly down-regulated. Over-expression
of miR-145 significantly inhibited the H2O2-induced cellular apoptosis, ROS production, mitochondrial structure disruption
as well as the activation of key signaling proteins in mitochondrial apoptotic pathway. These protective effects of miR-145
were abrogated by over-expression of Bnip3, an initiation factor of the mitochondrial apoptotic pathway in cardiomyocytes.
Finally, we utilized both luciferase reporter assay and western blot analysis to identify Bnip3 as a direct target of miR-145.
Our results suggest miR-145 plays an important role in regulating mitochondrial apoptotic pathway in heart challenged
with oxidative stress. MiR-145 may represent a potential therapeutic target for treatment of oxidative stress-associated
cardiovascular diseases, such as myocardial ischemia/reperfusion injury.
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Introduction
Myocardial infarction is one of the leading causes of morbidity
and mortality worldwide. While the development of cardiac
intervention techniques enables many patients to restore myocar-
dial perfusion, the subsequent ischemia-reperfusion injury may still
cause extensive cardiomyocyte death and acute heart dysfunction
[1]. To date, it has been widely accepted that cardiomyocyte death
under stress conditions is to a great extent a result of the activation
of the mitochondrial apoptotic pathway [2]. During ischemia-
reperfusion injury, cardiomyocytes typically undergo oxidative
stress mediated by reactive oxygen species (ROS). ROS activates
the mitochondrial apoptotic pathway (also named intrinsic
apoptotic pathway), which is featured by the alteration of
permeability of mitochondrial membrane and the release of
cytochrome C into cytoplasm to activate the caspase cascade
which ultimately lead to the degradation of genome DNA [3–4].
Despite of the essential role of the mitochondrial pathway in
oxidative stress-mediated cardiomyocyte apoptosis, how this
pathway is regulated at different levels remains elusive. MiRNA,
a class of small, non-encoding RNAs that transcriptionally or post-
transcriptionally modulate the expression of their target genes, has
been implicated as regulatory molecules in many cardiovascular
diseases, including myocardial ischemia-reperfusion injury [5–6].
MiR-145 is a tumor suppressor miRNA that has been recently
implicated in the regulation of apoptosis networks in tumor cells
through its ability of targeting various anti-apoptotic molecules [7–
9]. Moreover, the aberrant expression of miR-145 has been shown
to be associated with vascular smooth muscle cells’ response to
hydrogen peroxide (H2O2)-induced oxidative stress, indicating
that miR-145 may participate in the regulation of the oxidative
stress-triggered apoptosis and the regulation of the mitochondrial
apoptotic pathway [10]. However, little is known about whether
miR-145 is associated with cardiomyocyte apoptosis under
oxidative stress or how it interferes with the mitochondrial
apoptotic pathway.
Accumulating evidence indicates that BH3-only proteins such as
Bcl2/adenovirus E1B 19 kDa-interacting protein 3 (Bnip3) play
pivotal roles in the initiation of cardiomyocyte apoptosis, necrosis,
and autophagy [11]. Bnip3, which primarily localizes in the outer
membrane of mitochondria, functions not only as a sensor of
mitochondria to the oxidative stress in cytoplasm, but also as an
effector of the mitochondria-mediated apoptosis. Bnip3 transduces
the apoptotic signals through activating pro-apoptotic Bax/Bak
proteins, neutralizing the anti-apoptotic BH1–4 proteins, and
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promoting mitochondrial membrane depolarization by inducing
the formation of the pathological mitochondrial permeability
transition pore (mPTP) [11–12]. Indeed, Bnip3 has been shown to
be activated during apoptosis induced by multiple stimuli
including hypoxia and ischemia-reperfusion. In vitro enforcement
of Bnip3 expression promoted the cardiomyocyte apoptosis in a
caspase3-independent manner [13–15]. Targeting the expression,
localization, or activation of Bnip3 has thus been considered as a
potential strategy to salvage the ischemia-reperfusion-associated
cardiomyocytes apoptosis [14] [16–17].
Herein, we investigated the role of miR-145 in regulating
cardiomyocyte apoptosis and modulating the mitochondrial
apoptotic pathway in the setting of oxidative stress. Our results
demonstrated that miR-145 is substantially down-regulated in
cardiomyocytes with oxidative stress, and that over-expression of
miR-145 significantly inhibited the H2O2-induced cellular apop-
tosis, ROS production, mitochondrial structure disruption as well
as the activation of key signaling proteins in mitochondrial
apoptotic pathway. And these protective effects were at least
partially through directly targeting Bnip3.
Materials and Methods
Mice
Animal experiments were performed in 8–12-week-old male
C57 mice, which were purchased from the Animal Center of
Yangzhou University. The protocol was approved by the
Institutional Animal Care and Use Committee of the affiliated
Drum Tower Hospital of Nanjing University Medical School.
Animal Model of Ischemia/reperfusion (I/R) Injury
Forty male C57 mice were randomly divided into four groups:
sham 1 h, I/R 1 h, sham 3 h and I/R 3 h. Each group contains
10 mice. Surgical procedures were performed essentially as
previously described [18]. Briefly, for I/R 1 h group and I/R
3 h group, mice were subjected to 50 min myocardial ischemia via
ligation of the mid sections of left anterior descending arteries
followed by 1 and 3 h reperfusion respectively. For sham 1 h
group and sham 3 h group, animals were subjected to the
procedure of opening chest followed by suture at 1 h and 3 h later
respectively. The myocardial tissues bordering the primary
infarction zones with approximately equal sizes were collected
and stored in liquid nitrogen.
Primary Culture of Neonatal Rat Ventricular Myocytes
(NRVMs)
We obtained ventricles from 1-day-old Sprague-Dawley rats
and isolated cardiac myocytes through digestion with trypsin-
EDTA and type 2 collagenase as previously described [19]. The
protocol was approved by the Institutional Animal Care and Use
Committee of the affiliated Drum Tower Hospital of Nanjing
University Medical School. Briefly, the tissues were cut into small
pieces and digested by 0.25% trypsin at 4uC overnight.
Collagenase (Worthington, Lakewood, USA, 1 mg/ml in HBSS)
was used to further digest tissues in shaking bath at 37uC for
20 min. The cell suspension was centrifuged at 1,000 rpm for
5 min and resuspended in 10% fetal bovine serum (FBS) (GIBCO)
DMEM with 1 g/L glucose (GIBCO) and 10% FBS. Cells were
cultured for 2 hours to allow fibroblast cells to attach to the flask.
NRVMs were collected from the supernatants and cultured with
DMEM containing 1 g/L glucose plus 10% FBS and 1%
penicillin/streptomycin (GIBCO). Adenoviruses were used to
transduce cells at indicated multiplicity of infection (MOI). Cells
were further transfected with plasmid constructs 24 hours after
adenovirus transduction and stimulated with various concentra-
tions of H2O2 (Sigma, St. Louis, USA) from 48 hours later, for the
indicated time courses.
Generation of miR-145 Adenovirus
The miR-145 adenovirus used in this study contained human
miR-145 gene (has-miR-145), whose mature miRNA sequence is
identical to that of rat miR-145 (rno-miR-145). Adenoviruses
harboring a 441–base pair DNA fragment encompassing the hsa-
mir-145 gene (Ad-miR-145) were generated using the AdMax
(Microbix) systems according to the manufacturers’ recommenda-
tions. An adenovirus bearing LacZ (Ad-LacZ) was obtained from
Clontech. Viruses were packaged and amplified in HEK293 cells
and purified using CsCl banding, followed by dialysis against
10 mmol/L Tris-buffered saline with 10% glycerol. Titering was
performed on HEK293 cells using the Adeno-X Rapid Titer kit
(BD Biosciences Clontech, Palo Alto, CA, USA) according to the
manufacturer’s instructions.
Generation of Bnip3-CDS and Bnip3-CDS-39UTR
Constructs and Cardiomyocyte Transfection
Plasmid constructs containing the coding sequence (CDS) or the
coding sequence combined with the 39UTR of rat Bnip3
(GenBank, accession No. AF243515) were prepared by cloning
the indicated sequences into rAd-psilence-CMV vector (Applied
Biosystems, Carlsbad, USA). Namely, Bnip3-CDS contained
621 bp from +1 to +621 nt, and Bnip3-CDS-39UTR contained
1378 bp from +1 to +1378 nt (+1 designates the translation
starting site of rat Bnip3), including the two putative binding sites
for miR-145 which located in +1267,+1272 nt and
+1308,+1313 nt respectively. Both plasmid constructs were used
to transfect NRVMs using Effectene Transfection Reagent
(Qiagen, Cat.No. 301425). The transfection efficiency was evalu-
ated by transfecting eGFP-C1 empty vector (Clontech, Mountain
View, CA) into NRVMs and observing the fluorescence of GFP
under fluorescence microscopy (Leica DM2500-3HF-FL, Solms,
Germany). The transfection efficiency reached ,40%. MiR-145
inhibitor (rno-miR-145 inhibitor, Cat. No. miR2000437, RiBo
Bio, Guangzhou, China), was transfected using Lipofectamine
2000 (Invitrogen, Carlsbad, CA, USA) when indicated.
Luciferase Reporter Assay
Based on the rat Bnip3 mRNA sequence deposited in the
GenBank database (accession No. AF243515), the fire luciferase
cDNA fused with rat Bnip3 mRNA 39UTR containing the two
seed sequences for miR-145 (308 bp, +1012 to +1319 nt) and
39UTR without the seed sequence (198 bp, +1012 to +1209 nt)
were amplified separately from the genomic DNA of neonatal rat
ventricle myocytes (NRVM) and cloned into the pGL3-promoter
luciferase reporter vector (Promega, Madison, USA). Preconfluent
H9c2 cells, in 12-well plates, were transduced with Ad-LacZ and
Ad-miR-145 at indicated MOIs for 24 h, then cells were
transfected with 300 ng of firefly luciferase reporter plasmid
(pGL3-Luc-Bnip3 -39UTR or pGL3-Luc-Bnip3 -39UTRMU) and
20 ng of Renilla luciferase reporter plasmid pRL-RSV (Promega)
using Lipofectamine 2000 transfection reagent (Invitrogen). Cell
lysates were assayed for luciferase activity 48 h after transfection
using the Luciferase Assay System (Promega) according to the
instructions from the manufacturer. Firefly luciferase activity was
normalized for transfection efficiency by the corresponding Renilla
luciferase activity. All transfection experiments were performed at
least 5 times in duplicate.
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Quantitative Real-time PCR
Total RNA was extracted from cultured cells using Trizol
reagent (Invitrogen, Carlsbad, CA, USA) following the manufac-
turer’s instructions. Two micrograms of total RNA were reverse
transcribed in a total volume of 20 ml, and real-time PCR using
SYBR green fluorescence was performed (BIO-RAD) to detect
miR-145 expression as previously described [20]. Complementary
DNA was synthesized using a miR-145-specific stem-loop primer:
59-CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGA-
GAGGGATTC-39. Quantitative polymerase chain reaction used
the following primers: forward, 59- CGCGCTCGAGCCCA-
GAGCAATAAGCCACAT -39; reverse, 59-
GGTGTCGTGGAGTCGGCAATTCAGTTGAG-39. The
primers for small nuclear RNA U6 (U6) were: forward, 59-
CTCGCTTCGGCAGCACA-39; reverse, 59-AACGCTTCAC-
GAATTTGCGT-39. The reverse primer of U6 was also used in
reverse transcription of U6. PCR condition was 95uC for 15 min,
followed by 40 cycles at 95uC for 15 sec and 60uC for 1 min.
Samples were run in duplicate with RNA preparations from three
independent experiments. Each real-time PCR reaction consisted
of 2 ml RT product, 10 ml SYBR Green PCR Master Mix, and
500 nM forward and reverse primers. Reactions were carried out
on a MyiQ Single Color Real-time PCR Detection System (Bio-
Rad) The fold change in expression of each gene was calculated
using the 22ggCT method with U6 as an internal control.
Western Blotting Analysis
Cardiomyocytes were transduced with Ad-miR145 or Ad-LacZ
at 50 or 100 MOI and treated with 50 mM H2O2 or vehicle as
indicated. The whole lysates were used to detect cleaved caspase 3,
phosphorylated p53 (p-p53, Ser-15), Bnip3, Apaf-1, and b-actin.
Cytochrome C release was evaluated by detecting cytochrome C
in cytoplasmic and mitochondrial lysates. The isolated mitochon-
drial lysates were also used to detect Bnip3, COX IV or VDAC.
The primary antibodies were as follows: cytochrome C, Bnip3, p-
p53 (Ser-15), Apaf-1, COX IV and Cleaved Caspase 3 (Asp-175),
all of which were rabbit polyclonal antibodies from Bioworld
Corporation (Dublin, USA); anti-VDAC rabbit polyclonal anti-
body from Cell signaling Technology Inc (Danvers, USA) and
anti-b-actin mouse monoclonal antibody from Bioworld Corpo-
ration (Dublin, USA).
TUNEL Assay
For TUNEL staining, cells were cultured in chambers (Milipore,
Billerica, USA) at a density of 105 cells/chamber and transduced
with Ad-miR-145 or Ad-LacZ. The miR-145 inhibitor along with
control inhibitor was transfected 24 hours after adenoviruses
transduction. 48 hours after transduction, 50 mM H2O2 were
added to the cells for 2 hours. After treatment, cells were fixed by
4% paraformaldehyde and TUNEL staining was performed using
the In Situ Cell Death Detection Kit (Roche, Mannheim,
Germany) according to the manufacturer’s instructions.
ELISA for DNA Ladder Detection
DNA ladder detection was performed according to the
instruction of Cell Death Detection ELISAPlus (Roche). Briefly,
cells cultured in 12-well plate were washed twice with PBS to
remove the necrosis. Lysis buffer was used to lyse the cells for
Figure 1. MiR-145 expression was down-regulated in ischemia/reperfused heart and H2O2-treated NRVMs. (A), Quantitative real-time
PCR showed that miR-145 expression in ischemic myocardium tissues undergoing 1 hour and 3 hours reperfusion was down-regulated, compared
with that in the respective sham groups. (n = 10 in each group). (B), Primary neonatal rat ventricle myocytes (NRVM) were treated with 50 mM H2O2 for
indicated time courses ranging from 0.5 hour to 8 hours. Real-time PCR revealed that miR-145 expression was down-regulated in NRVMs treated with
H2O2. (C), western blot demonstrated that p53 protein levels were increased at 15 min and 30 min after treatment with H2O2, but decreased
afterwards. Data are presented as means 6 SEM. Significance is indicated as *p,0.05 and **p,0.01, as determined by student’s t test.
doi:10.1371/journal.pone.0044907.g001
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30 min at room temperature, followed by incubation with the
immunoreagent containing anti-histone-biotin and anti-DNA-
POD for 2 hours with gentle shaking. Substrate buffer (ABTS)
was added to develop the color and the results were presented as
absorbance A405–A490.
DCFH-DA Staining
29,79-Dichlorodihydrofluorescein diacetate (DCFH-DA) dye
(Sigma) was diluted with DMEM medium and added to the living
cells cultured in chambers. Cells were then incubated in 5% CO2
at 37uC for 50 min and washed twice with PBS. Chambers were
subject to confocal microscopy examination.
Electron Transmission Microscopy
Cells were harvested by a gentle digestion with 0.25% trypsin
and fixed with 2% glutaraldehyde. Osmium tetroxide (1% in
0.1 mol/L cacodylate) was used for postfixation. Copper grids
were stained with 2% uranyl acetate followed by dehydration with
series of ethanol. Samples were embedded with epoxy resin and
polymerized at 60uC. The images were acquired from electron
transmission microscopy (JEOL JEM-1400, Tokyo, Japan) scan.
Statistics
All data were presented as the means6SE from at least three
independent experiments. Statistical analysis was performed by
Student’s t test, using SPSS software. Statistic significance was
demonstrated as *, or **, with * indicating p,0.05, and **
indicating p,0.01.
Results
Expression of MiR-145 was Down-regulated in the Heart
in Response to I/R Injury
To investigate whether miR-145 expression is altered during
myocardial I/R injury, Stem-loop real-time PCR was used to
detect the miR-145 mRNA levels in ischemia/reperfused myo-
cardial tissues. As shown in figure 1A, the expression level of miR-
145 was significantly decreased, by approximately 50%, in
reperfused myocardial tissues. Likewise, in cultured cardiomyo-
cytes treated with 50 mM H2O2 for 0.5 hour to 8 hours, the miR-
145 mRNA levels were significantly down-regulated (figure 1B).
Since previous studies suggest a role of p53 in regulating miR-145
expression [21], we further detected the p53 expression in H2O2-
treatment cardiomyocytes through western blot and found that the
protein levels of p53 increased in the first 30 min following H2O2
treatment, but decreased afterwards (figure 1C).
Over-expressing miR-145 Attenuated H2O2-induced
Apoptosis in Cardiomyocytes
To determine whether miR-145 plays a role in the regulation
of H2O2-induced apoptosis in cardiomyocytes, we performed
the adenovirus-mediated over-expression of miR-145. Quantita-
tive real-time PCR was performed to evaluate the miR-145
levels in cultured cardiomyocytes either transduced with Ad-
miR145 or transfected with miR-145 inhibitor. In fact,
cardiomyocytes express a high level of endogenous miR-145
(Ct value ,12, data not shown) and transduction of cardiomy-
ocytes with Ad-miR145 further increased the level of miR-145
in a dose-dependent manner (figure 2A). Transfection of miR-
145 inhibitor significantly suppressed the miR-145 expression
(figure 2B). Noticeably, over-expression of miR-145 substantially
inhibited the H2O2 induced cardiomyocyte apoptosis, as
determined by TUNEL staining and DNA ladder ELISA,
whereas transfection of miR-145 inhibitor increased the rate of
H2O2-induced cardiomyocyte apoptosis (figure 3A–C). Further-
more, the anti-apoptotic effect of miR-145 was neutralized
when Bnip3, one of the predicted miR-145 targets, was over-
expressed. In both DNA ladder ELISA and TUNEL assay,
over-expression of either Bnip3 CDS (containing only coding
sequence of Bnip3) or Bnip3 CDS/39UTR (containing coding
sequence combined with the 39UTR of Bnip3) resulted in an
increased apoptosis rate of cardiomyocytes, in both normal and
oxidative context. MiR-145 significantly lowered the apoptosis
rate in the existence of Bnip3 CDS/39UTR, but had mild effect
in the existence of Bnip3 CDS (figure 3A–C). Taking together,
these results suggest that miR-145 plays a protective role against
the oxidative stress-induced cardiomyocyte apoptosis and this
regulation of miR-145 is linked with Bnip3. Since Bnip3 is
directly involved in the mitochondrial apoptotic pathway, we
asked whether miR-145 could regulate the mitochondrial
apoptotic pathway. We thus performed western blot to detect
the expression levels of key molecules in the mitochondrial
apoptotic pathway, such as cleaved caspase 3, Apaf-1,
phosphorylated p53 (S15), cytochrome C, and mitochondrial
Bnip3. Indeed, H2O2 treatment markedly increased the levels of
cleaved caspase 3, which were only slightly decreased by miR-
Figure 2. Expression of miR-145 in cardiomyocytes either
transduced with Ad-miR145 and transfected with miR-145
inhibitor. Quantitative real time PCR revealed that the expression
levels of miR-145 were increased after Ad-miR145 transduction (25–100
MOIs) (A), but suppressed by miR-145 inhibitor in a dose-dependent
manner (50–100 nM) (B) in cultured NRVMs. Data are presented as
means 6 SEM. Significance is indicated as *P,0.05 and **P,0.01, as
determined by student’s t test.
doi:10.1371/journal.pone.0044907.g002
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145 over-expression. The levels of Apaf-1, cytoplasmic cyto-
chrome C, and mitochondrial Bnip3 were significantly increased
in cells treated with H2O2, but markedly decreased by over-
expression of miR-145 in a dose-dependent manner (figure 4A).
Consistent with apoptosis detection assays, over-expression of
either Bnip3 CDS or Bnip3 CDS/39UTR triggered cytochrome
C release, whereas over-expression of miR-145 suppressed the
Bnip3 CDS/39UTR-induced cytochrome C translocation
(figure 4B). These results support that miR-145 regulated
cardiomyocyte apoptosis through modulating the mitochondrial
apoptotic pathway.
MiR-145 Protected Against Mitochondrial Structure
Disruption and Inhibited ROS Production
Since the activation of the mitochondrial apoptotic pathway in
cardiomyocytes typically causes the structural changes and
dysfunction of mitochondria [1] [4], we attempted to investigate
the effect of miR-145 upon mitochondrial morphology. Treatment
of the Ad-LacZ transduced cells with 50 mM H2O2 for 2 hours led
to a massive swelling of mitochondria and loss of cristae, as
determined by electron transmission microscopy (figure 5A). In
contrast, in miR-145-over-expressing cardiomyocytes, although
small vesicles were presented in mitochondria, the outer mem-
branes of mitochondria were largely intact, the cristae were
evident, and the organization of mitochondria was neat and
regular (figure 5A). We also detected the overall ROS generation
by using a ROS-sensitive dye 29,79-dichloruorescein-diacetate
(DCFH-DA) [22]. As shown in Figure 5C, H2O2 and Bnip3 CDS,
separately or combinatorially led to a strong staining of DCFH-
DA, whereas miR-145 produced a relatively dim DCFH-DA
staining in cardiomyocytes treated with H2O2 and co-expressing
Bnip3 CDS/39UTR (figure 5B), suggesting that miR-145 atten-
uated the production of ROS and Bnip3 might be at its
downstream.
Figure 3. MiR-145 inhibited H2O2-induced apoptosis in cultured NRVMs. For both DNA ladder ELISA and TUNEL assay, cultured NRVMs were
transduced with Ad-LacZ or Ad-miR-145 (MOI = 100) and transfected with either 0.5 mg Bnip3 CDS or Bnip3 CDS/39UTR or rAd-psilence empty vector
per 106 cells; and then transfected with 10 nM miR-145 inhibitor or control inhibitor per 106 cells. Cells were treated with vehicle or 50 mM H2O2 for 2
hours. In DNA ladder ELISA (A), apoptosis of cardiomyocytes in different group was evaluated by calculating A405 nm-A490 nm values. The result
shows that miR-145 protected against H2O2-induced cardiomyocytes apoptosis, which was significantly enhanced by Bnip3. In TUNEL staining assay
(B), the percentage of cell apoptosis was calculated by the following formula: number of TUNEL (red)-positive cells/number of DAPI (blue)-positive
cells. The rates were calculated in 10 randomly chosen fields from each group. Scale bar indicates 50 mm. C, the quantitative analysis of
cardiomyocyte apoptosis was determined by TUNEL staining assay. Data are presented as means 6 SEM. Significance is indicated as *P,0.05 and
**P,0.01, as determined by student’s t test.
doi:10.1371/journal.pone.0044907.g003
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PLOS ONE | www.plosone.org 5 September 2012 | Volume 7 | Issue 9 | e44907
MiR-145 Regulated Bnip3 Expression through Targeting
its 3’UTR
To examine whether Bnip3 is a direct target of miR-145, we
resorted to luciferase reporter assay. Before, it has been reported
that human Bnip3 was a direct target of miR-145 [15]. Sequence
analysis of rat BNIP-39UTR revealed two putative miR-145
binding sites located at 1267–1272 nt and 1308–1313 nt, which is
highly conserved in both Homo sapiens and Rattus norvegicus
(figure 6A). Accordingly, we constructed two reporter plasmids by
cloning the rat Bnip3 39UTR containing or without the two miR-
145 putative binding sites (1267–1272 nt and 1308–1313 nt)
(designated as WT and mutant, respectively) into the 39UTR of
pGL3 vector. Indeed, over-expression of miR-145 markedly
down-regulated the activity of luciferease gene fused with the
Bnip3 WT-39-UTR (luc-Bnip3 39UTR). In contrast, over-expres-
sion of miR-145 barely affected the activity of luciferase gene fused
with the Bnip3 39-UTR mutant (luc-Bnip3 39UTR-MU)
(figure 6B). The protein level of Bnip3 also saw a marked dose-
dependent down-regulation when Ad-miR-145 was transduced at
different MOIs (0, 50, and 100) (Figure 6C). Taking together, these
results suggest that Bnip3 is a direct target of miR-145 in
cardiomyocytes. MiR-145 regulated Bnip3 expression through
targeting the specific binding cites in the 39UTR of Bnip3.
Discussion
Clinically, myocardial ischemia-reperfusion is an acute and
severe injury and the extensive apoptosis and necrosis of
cardiomyocytes at the earliest stage of reperfusion account for
most of the clinical manifestations [1]. At cellular level, oxidative
stress, calcium overload and ATP depletion are three essential
pathological features of the reperfused heart cells and are closely
connected with the activation of the mitochondrial apoptotic
pathways [23]. Recently, an emerging role of microRNAs in
regulating mitochondrial functions has been explored in cardio-
myocytes [24] [20]. Here, we demonstrate that miR-145 protects
against the activation of mitochondria apoptotic pathway in
cardiomyocytes under oxidative stress through directly targeting
mitochondrial membrane protein Bnip3.
Figure 4. MiR-145 modulated the expression levels of key apoptosis mediators. (A), The levels of key apoptosis mediators in mitochondria
apoptosis pathway, including cleaved caspase3, phospho-p53 (S15), Apaf-1, mitochondrial Bnip3, cytochrome C in mitochondria and cytoplasm, were
determined by western blotting analyses. b-actin and VDAC were used as loading controls for cytoplasmic protein and mitochondrial protein
detections respectively. The result shows that miR-145 over-expression inhibited the activation of mitochondrial apoptotic pathway. (B), cultured
NRVMs were transduced with either Ad-miR-145 or Ad-LacZ (MOI = 100) and then transfected with either 1 mg Bnip3 CDS or Bnip3 CDS/39UTR or rAd-
psilence empty vector per 106 cells. 48 hr after transfection, cells were then transfected with 20 nM either miR-145 inhibitor or control inhibitor per
106 cells. Protein levels of Bnip3 (total Bnip3), cytochrome C in mitochondria, and cytoplasm (cytochrome C release) were detected by western
blotting. b-actin and COX IV served as loading controls for cytoplasmic and mitochondrial proteins, respectively. The result shows that miR-145
protected against Bnip3-induced cytochrome C release. All results were repeated in three independent experiments.
doi:10.1371/journal.pone.0044907.g004
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MiR-145 was considered to be a tumor suppressor microRNA
and was shown to suppress tumor cell proliferation and induce cell
apoptosis in a variety of tumor cell lines [7–9] [25]. The functional
significance of miR-145 in the heart, however, has not been
explored thus far. In the present study, we demonstrated that miR-
145 exerted a potent protective effect against the oxidative stress-
induced apoptosis in cardiomyocytes (figure 3A–C). Previously,
miR-145 has been shown to inhibit tumor growth mostly through
targeting pro-proliferative molecules such as p70S6K and c-myc
[25–26]. However, in cardiomyocytes, we found that miR-145
modulated the mitochondrial pathway by directly targeting key
intermediates in the mitochondrial apoptosis machinery (figure 4,
6C). Indeed, the expression of miR-145 has been shown to be
down-regulated in a variety of cancer cells as we observed here in
cardiomyocytes treated with H2O2 (figure 1B). However, this
down-regulation may result in different cellular behaviors, since
most cancer cells, unlike cardiac myocytes, are far less sensitive to
the toxicity of ROS and the pathological mPTP opening [27]. The
down-regulation of miR-145 was also noted in vascular smooth
muscle cells treated with H2O2 [10]. Nevertheless, the mechanism
of the down-regulation of miR-145 by oxidative stress is unclear.
p53 has been identified to positively regulate miR-145 maturation
[28]. In tumor cells, the p53 mutation and hypermethylation of
miR-145 promoter seem to primarily account for the miR-145
down-regulation [21]. In our study, p53 was found to be
transiently up-regulated at 15 min and 30 min following the
treatment of H2O2, but was subsequently decreased at 1 hour and
2 hour (figure 1C), while miR-145 was continuously down-
regulated from 30 min to 8 h after H2O2 treatment, indicating
that besides p53, alternative mechanisms may be involved in
regulating the miR-145 expression in cardiomyocytes. Thus, it
would be interesting to investigate whether a change of
methylation status in miR-145 promoter or an aberrant processing
of pre-miR145 may account for the miR-145 down-regulation in
cardiomyocytes in response to oxidative stress.
In the present study, we identified Bnip3 as a direct target of
miR-145 in rat cardiomyocytes. Indeed, ectopic expression of
Bnip3 significantly induced apoptosis in cardiomyocytes and this
was partially inhibited when miR-145 was over-expressed. These
results show that the protection of miR-145 against cardiomyo-
cytes oxidative stress is, at least in part, functionally attributed to its
suppression of Bnip3. It is interesting that Bnip3 has recently been
shown to transduce the apoptotic signal in a caspase-independent
manner [15] [29]. Conventionally, the mitochondrial apoptotic
pathway constitutes of the release of mitochondrial proteins such
as cytochrome C into cytoplasm, followed by the activation of
Figure 5. MiR-145 protected against H2O2-induced mitochondrial structural disruption and decreased the ROS production. For both
electron transmission microscopy and ROS staining, NRVMs were transduced with Ad-miR-145 or Ad-LacZ (MOI = 100) and transfected with either
1 mg Bnip3 CDS or Bnip3 CDS/39UTR or rAd-psilence empty vector per 106 cells, and then treated with 50 mM H2O2 for 2 h. (A), under electron
transmission microscopy, it was shown that miR-145 attenuated H2O2-induced mitochondrial structural disruption (swelling, rupture and loss of
cristae). Forced expression of Bnip3 CDS enhanced mitochondrial disruption and abrogated the protective effect of miR-145. Scale bars indicate
0.5 mm. (B), ROS staining was performed using DCFH-DA, and was observed with confocal microscopy. The panels show that miR-145 reduced H2O2-
triggered ROS production, which was promoted by Bnip3. The result represents the study of three independent experiments.
doi:10.1371/journal.pone.0044907.g005
Figure 6. MiR-145 suppressed expression of Bnip3 through binding to its 39UTR. (A), a representative illustration of the putative binding
sites for miR-145 in rat Bnip3 39-UTR. (B), miR-145 targets two seed sequences (+1267,+1272 nt and +1308,+1313 nt) of Bnip3 39-UTR. Luciferase
assay was performed in H9c2 cells using pGL3 reporter vector fused with either Bnip3 wild-type 39-UTR or Bnip3 39-UTR mutant. Over-expression of
miR-145 significantly decreased the activity of luciferase gene fused with Bnip3 wild-type 39-UTR, but had no effect on the activity of luciferase fused
with Bnip3 39-UTR mutant; (C), Detection of Bnip3 expression by western blot in the whole lysates of NVRMs transduced with different dosages of Ad-
miR-145 (50 and 100 MOI). The result showed that the protein level of Bnip3 was suppressed by miR-145 in a dose-dependent manner. Data are
presented as means 6 SEM. Significance is indicated as *P,0.05 and **P,0.01, as determined by student’s t test.
doi:10.1371/journal.pone.0044907.g006
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caspase proteins. However, in the adult heart, the expression levels
of caspase proteins are low and the caspase-dependent apoptosis
machinery is largely silenced [15]. Indeed, our findings support
this viewpoint by showing that the protein levels of released
cytochrome C and Apaf-1 were markedly decreased by miR-145
over-expression, whereas the protein levels of cleaved caspase3
were only moderately decreased. Considering that Apaf-1
functions as a linker between cytochrome C and caspase proteins
[30], our results suggest there exist non-caspase signaling pathways
linking cytochrome C and Apaf-1 to the DNA degradation and
miR-145-mediated protection against cardiac apoptosis may be
through these alternative pathways. Coincidently, in urothelial
cancer cell line, miR-145 also induces a caspase3-independent cell
death [8], in a similar way to the caspase-independent apoptosis
mediated by Bnip3 [15]. Together, these data support an essential
role of miR-145 in the regulation of the mitochondrial machinery
through modulating the levels of molecules upstream of caspase
activation [8].
The increased ROS level is a hallmark in oxidative stress
induced cardiomyocyte apoptosis. Strategies to interrupt the cycle
of ROS production may be hopeful in apoptosis salvage [31].
Excessive amount of ROS not only alters the redox environment
in cytoplasm and disrupts mitochondrial membrane, but also
facilitates Bnip3 activation by allowing Bnip3 to insert into the
mitochondrial membrane. Strikingly, we demonstrated that miR-
145 over-expression markedly attenuated the production of ROS
in cardiomyoctes in response to oxidative stress, suggesting that
miR-145 may exert the cardioprotective effects through regulating
not only the expression of Bnip3, but also the activation of it.
In summary, we have demonstrated that the expression of
miR-145 is substantially down-regulated in both ischemia/
reperfused heart and H2O2-treated cardiomyocytes and that
miR-145 over-expression confers cardiac protection against
oxidative stress-induced cardiomyocyte apoptosis through direct-
ly inhibiting the Bnip3 expression and the ROS generation
under oxidative stress conditions. Since oxidative stress is a
common pathological factor shared by many cardiovascular
diseases, such as cardiac hypertrophy, cardiomyopathy, and
acute myocardial infarction [31–32], identification of miR-145
as a novel cardioprotective molecule may potentially enable us
to develop additional therapeutic strategies for prevention and
treatment of cardiovascular disease.
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